393 studies found for:    Open Studies | "Diabetes Mellitus, Type 1"
Show Display Options
Rank Status Study
21 Recruiting A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: LY900014;   Drug: Insulin Lispro
22 Recruiting GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: GAD-Alum;   Drug: Vitamin D
23 Recruiting A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: LY900014;   Drug: Insulin Lispro
24 Not yet recruiting A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Insulin Lispro
25 Recruiting Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment
Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: human pancreatic islet transplantation
26 Not yet recruiting Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric New-onset Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Diabetic Ketoacidosis
Interventions: Drug: Glargine;   Drug: IV insulin;   Other: Electrolyte Correction;   Other: Correction of Fluid Loss
27 Not yet recruiting A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Insulin Lispro
28 Recruiting Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: empagliflozin medium dose;   Drug: empagliflozin low dose;   Drug: empagliflozin high dose;   Drug: placebo
29 Recruiting Empagliflozin as Adjunctive to inSulin thErapy in Type 1 Diabetes Over 52 Weeks (EASE-2)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo
30 Recruiting PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Gan & Lee insulin glargine followed by Lantus;   Drug: Lantus followed by Gan & Lee insulin glargine
31 Recruiting Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
32 Not yet recruiting Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Faster-acting insulin aspart;   Drug: insulin degludec;   Drug: insulin aspart
33 Not yet recruiting Empagliflozin and ACEi Effects on Hyperfiltration in Type 1 Diabetes (BETWEEN Study)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo (matching empagliflozin);   Drug: ramipril
34 Not yet recruiting Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Condition: Type 1 Diabetes
Interventions: Drug: Victoza®;   Drug: Placebo
35 Recruiting A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: NNC0143-0406;   Drug: insulin aspart
36 Not yet recruiting Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Faster-acting insulin aspart;   Drug: insulin aspart;   Drug: insulin degludec
37 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
38 Recruiting Beta Cell Function in (Pre)Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Glucose;   Device: Continuous glucose monitoring
39 Recruiting Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: NNC0114-0006;   Drug: liraglutide;   Drug: placebo
40 Recruiting Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Hypoglycemia Reduction in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Device: Diabetes Assistant (DiAs) (Unified Safety System (USS) Virginia);   Device: Sensor-Augmented Pump Therapy (placebo)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years